DalsnaFinance

Florida Cancer Specialists & Research Institute Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and Experience

Markets PR Newswire By PR Newswire 28 May 2026 14:35 1 min read
Florida Cancer Specialists & Research Institute Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and Experience

Findings to be presented at 2026 ASCO® Annual Meeting FORT MYERS, Fla., May 28, 2026 /PRNewswire/ -- Key findings from a study conducted with the participation of Florida Cancer Specialists & Research Institute, LLC (FCS) found comparable quality and safety outcomes across care delivery...

Findings to be presented at 2026 ASCO® Annual Meeting FORT MYERS, Fla., May 28, 2026 /PRNewswire/ -- Key findings from a study conducted with the participation of Florida Cancer Specialists & Research Institute, LLC (FCS) found comparable quality and safety outcomes across care delivery...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.